For U.S. Healthcare Professionals Only


Apidra® savings for eligible patients with and without health insurance*

Support Resources for Commercial Patients—$0* Co-Pay Offer

  • This program has been available for over 5 years as a $0* copay with a maximum savings of up to $100 for your monthly prescription

  • Offer valid for Apidra Solostar® pens and Apidra vials

Your patients can register or activate their card by visiting

Your patients using a mail order pharmacy can still use this savings offer if they activate a copay card and submit for a rebate up to the maximum savings limit. See more at or call 855-443-1577

If you or your office needs additional information

call 855-443-1577 8 AM - 8 PM ET M-F (except holidays)

Support Resources for Patients without Insurance

If your patients don't have prescription medication insurance they can use Sanofi Insulins Valyou Savings Program:

  • Your patients pay $99* for their monthly supply of any one or combination of Sanofi Insulins*
  • Guaranteed one monthly set price for up to 10 vials and/or packs of pens per fill of any Sanofi Insulins

Sanofi insulins included in this program are: APIDRA® (insulin glulisine injection) 100 Units/mL, ADMELOG® (insulin lispro injection) 100 Units/mL, TOUJEO® (insulin glargine injection) 300 Units/mL and LANTUS® (insulin glargine injection) 100 Units/mL

Patients must fill all their Sanofi Insulin prescriptions at the same time, together each month.
The Insulins Valyou Savings Program applies to the cost of medication. There are other relevant costs associated with overall treatment. This offer is not valid for the SOLIQUA 100/33 (insulin glargine and lixisenatide injection) 100 Units/mL and 33 mcg/mL.

*Terms & Restrictions Apply

Learn more about Insulins Valyou Savings Program

If your patients need additional financial assistance, click here

Learn more about Savings Offers on other Sanofi Insulins

Request Samples

Order samples today to help your patients get started with Apidra


About Apidra

Learn how rapid-acting Apidra works to mimic the secretion pattern of endogenous human insulin.

Clinical results

See how Apidra performed in a 24-week OPAL study.


Get information about how to initiate and dose Apidra using the AACE Algorithm.